Conception
Conception is developing in-vitro gametogenesis (IVG) technology to convert induced pluripotent stem cells into viable human eggs, enabling older individuals and couples facing infertility to have biological children. This approach aims to eliminate barriers to reproduction and may facilitate genetic screening to reduce the risk of hereditary diseases in future generations.
- Biotechnology
Funding
Raised to date
$38MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$20M across 1 disclosed round
CJTSA$20M · Series A
Announced Nov 2021
Disclosed cumulative: $20M
Reported total $38M
Incomplete round history. $18M of the $38M reported total isn’t matched to a known round.
Founders
Product
Problem
In vitro fertilization (IVF) is limited by the availability of viable eggs, particularly for older individuals, couples facing infertility, and same-sex male couples. Current methods also lack the ability to comprehensively screen for and reduce the risk of inherited diseases in future generations.
Solution
Conception is developing in-vitro gametogenesis (IVG) technology to generate viable human eggs from induced pluripotent stem cells (iPSCs). This technology aims to overcome limitations in egg availability and enable individuals and couples to have biological children who otherwise could not. By creating eggs from stem cells, the platform may also facilitate comprehensive genetic screening of the eggs to reduce the risk of hereditary diseases in future generations. The company focuses on process optimization and quality control measures to ensure the safety and health of the generated eggs.
Target Audience
The primary target audience includes individuals and couples facing infertility, older individuals who wish to have biological children, and same-sex male couples.
Features
- Generation of induced pluripotent stem cells (iPSCs) from blood samples.
- Differentiation of iPSCs into viable human eggs in a laboratory setting.
- Reconstitution of the natural egg development process in vitro.
- Development of rigorous process optimization and quality control measures.
- Application of the technology to create viable mouse eggs as a proof of concept.